Pharmanutra S.p.A.

PHN

IT0005274094

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 14:54:13 27/06/2024 BST			5-day change	1st Jan Change
47.7 ^EUR	+1.27%		+0.53%	-15.43%

06-19	Mib slightly up; bond issue for Enel	AN
06-18	Mib up, Saipem and banks well	AN

Pharmanutra expands into Mexico after contract with SMS Pharma

June 18, 2024 at 10:38 am

(Alliance News) - PharmaNutra Spa on Tuesday announced that it will begin a new step of expansion in foreign markets, specifically in Mexico.

The company's foreign team recently participated in the launch event for the three products that will be distributed in Mexico starting this month, following the contract signed in November 2022 with partner SMS Pharma.

These are a group of companies founded in 2009, specializing in the development and implementation of business models and demand generation, with a focus on the pharmaceutical and healthcare products market.

PharmaNutra on Tuesday trades in the red by 1.3 percent at EUR45.65 per share.

By Maurizio Carta, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Pharmanutra S.p.A.

Mib slightly up; bond issue for Enel	06-19	AN
Mib up, Saipem and banks well	06-18	AN
Pharmanutra expands into Mexico after contract with SMS Pharma	06-18	AN
PharmaNutra kicks off over EUR1 million buyback plan	06-12	AN
Milan up tentatively; Leonardo and banks do well	05-31	AN
Mib pegs 34,300; banking segment well	05-30	AN
Futures up; focus on inflation data	05-28	AN
Mib rises and ECB cuts in sight; boost on Zignago	05-27	AN
Sell on stock markets; Danske revises ECB cut estimates	05-24	AN
Pharmanutra S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Indices expected to rise ahead of macro data	05-15	AN
Mib on highs since 2008 dragged by banks	05-14	AN
PharmaNutra, profit down sharply in quarter; revenues improve	05-13	AN
Lists in green except Mib; banks good	04-22	AN
Iveco down on Mib; European stock exchanges in green	04-22	AN
Futures await bourses up; China holds rates	04-22	AN
Mib closes bullish; Terna takes top spot	04-19	AN
PharmaNutra Gets Approvals to Merge Subsidiaries	04-15	MT
PharmaNutra approves merger of Junia Pharma and Alesco	04-15	AN
Futures passive; BoJ abandons negative rates.	03-19	AN
Milan at parity; De Nora on bottom after accounts	03-18	AN
PharmaNutra increases revenues to double digits in 2023	03-15	AN
Pharmanutra S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Mib at peak since 2008; MPS updates annual max	03-01	AN
Mib rallying; Saipem still bullish after accounts	03-01	AN

Chart Pharmanutra S.p.A.

Duration

Period

More charts

Company Profile

Pharmanutra SpA is an Italy-based company engaged in the healthcare industry. The Company develops nutraceutical products and medical devices. It focuses on studying and producing formulations that are backed up in scientific research. It is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The Company offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Sector

Pharmaceuticals

Calendar

08/09/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Pharmanutra S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

47.1 EUR

Average target price

80.33 EUR

Spread / Average Target

+70.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PHARMANUTRA S.P.A.	-15.43%	484M
ELI LILLY AND COMPANY	+54.85%	811B
NOVO NORDISK A/S	+43.96%	640B
JOHNSON & JOHNSON	-6.10%	353B
MERCK & CO., INC.	+19.68%	333B
ABBVIE INC.	+10.20%	302B
ASTRAZENECA PLC	+17.47%	246B
ROCHE HOLDING AG	+2.41%	225B
NOVARTIS AG	+12.81%	218B
AMGEN INC.	+9.04%	168B

Other Pharmaceuticals

Pharmanutra S.p.A.

Equities

PHN

IT0005274094

Pharmaceuticals

Pharmanutra expands into Mexico after contract with SMS Pharma

EPS Revisions